Silence Therapeutics SLN Earnings Call Transcripts

NASDAQ SLN
$19.79 +0.04 (+0.20%)
At close: Nov 10, 2026 · 4:00 PM EST
2 earnings calls on file for Silence Therapeutics, from Q4 2020 to Q2 2021. Each transcript opens in a new tab.
Latest earnings call

Silence Therapeutics Q2 2021 Earnings Call

Aug 12, 2021 5,727 words · 25 min read
  • Gem HopkinsInvestor Relations and Corporate Communications
  • Mark RotheraPresident and Chief Executive Officer
  • Giles CampionHead of R&D and Chief Medical Officer
  • Craig ToomanChief Financial Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Silence Therapeutics Earnings Call Transcripts

Calls2
LatestAug 12, 2021
SinceQ4 2020

Fiscal 2021

Fiscal 2020

All 2 Silence Therapeutics transcripts Register to get access to Silence Therapeutics’s earnings call transcripts.